We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Kerry Group Plc | LSE:KYGA | London | Ordinary Share | IE0004906560 | 'A'ORD EUR0.125 (CDI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.90 | 0.97% | 93.40 | 93.30 | 93.90 | 94.00 | 93.40 | 93.60 | 3,457 | 15:08:50 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Food Preparations, Nec | 8.02B | 728.3M | 4.1150 | 22.82 | 16.37B |
From Jan 2020 to Jan 2025
TIDMKYGA
RNS Number : 0878P
Kerry Group PLC
15 February 2021
15 February 2021
LEI: 635400TLVVBNXLFHWC59
KERRY GROUP
Kerry Group plc announces its intention to acquire Biosearch Life
Dublin, IRELAND: Kerry Group plc has announced its intention to acquire the Spanish company Biosearch Life.
Based in Granada, Spain and employing over 150 employees, Biosearch Life is a leader in the nutraceutical and functional food sectors. The company has an extensive range of probiotics and is a recognised leader in premium probiotics obtained from human breast milk (Hereditum (R) brand), scientifically backed innovative botanical extracts (Exxentia (R) ) and natural omega-3 (Eupoly-3 (R) brand).
The acquisition is envisaged to be completed by means of a friendly public tender offer for the shares of Biosearch Life addressed to all of its shareholders and is subject to the prior approval of the Spanish National Securities Markets Commission and, upon its approval, to the acceptance of the offer by Biosearch Life's shareholders. Grupo Lactalis Iberia, S.A., main shareholder of Biosearch Life, has irrevocably undertaken to tender its entire stake representing 29.5% of the share capital of the company into the offer.
For further details on the terms and conditions of the offer please see the offer announcement published on the following link: verDoc.axd (cnmv.es)
ENDS
Hot Features
Premium
CONTACT INFORMATION
=============================================
Media
Catherine Keogh , VP Corporate Affairs
& Communications
+353 45 930188 | corpaffairs@kerry.com
Investor Relations
Marguerite Larkin , Chief Financial
Officer
+353 66 7182292 | investorrelations@kerry.ie
William Lynch , Head of Investor
Relations
+353 66 7182292 | investorrelations@kerry.ie
Website
www.kerrygroup.com
About Kerry
Kerry, the Taste & Nutrition company, offers solutions that nourish lives all over the world. From humble beginnings as an Irish dairy co-operative, Kerry has grown into a large international food industry leader, with offices in 32 countries, 149 manufacturing facilities and more than 26,000 employees globally, including over 1,000 food scientists. It brings to the table a strong food heritage, coupled with over 40 years of experience, global insights and market knowledge, culinary and applications expertise, as well as a range of unique solutions that anticipate and address customers' needs. For more information, visit kerrygroup.com .
About Biosearch Life
Biosearch Life is a biotechnology company focused on providing innovative solutions worldwide in the pharmaceutical, nutraceutical and functional food sectors providing a wide range of high-quality products and services which revolve around the concept of a healthy life. The company has a range of products in three primary areas: probiotics, omega-3 fatty acids and botanical extracts. Biosearch Life distributes its products across Europe, Asia and the USA and has an average annual workforce of over 150 employees.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ACQSFSSAIEFSEFE
(END) Dow Jones Newswires
February 15, 2021 03:13 ET (08:13 GMT)
1 Year Kerry Chart |
1 Month Kerry Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
